 |
Previous Article | Next Article 
The Journal of Neuroscience, January 1, 1999, 19(1):180-192
Regulation and Immunohistochemical Localization of
 -Stimulated Adenylyl Cyclases in Mouse Hippocampus
Lauren P.
Baker,
Mark D.
Nielsen,
Soren
Impey,
Beth M.
Hacker,
Steven W.
Poser,
Mandy
Y. M.
Chan, and
Daniel R.
Storm
Department of Pharmacology, University of Washington, Seattle,
Washington 98195-7280
 |
ABSTRACT |
Specific forms of synaptic plasticity such as long-term
potentiation (LTP) are modulated by or require increases in cAMP. The
various adenylyl cyclase isoforms possess unique regulatory properties,
and thus cAMP increases in a given cell type or tissue in response to
converging signals are subject to the properties of the adenylyl
cyclase isoforms expressed. In most tissues, adenylyl cyclase activity
is stimulated by neurotransmitters or hormones via stimulatory
G-protein (Gs)-coupled receptors and is inhibited via inhibitory G-protein (Gi)-linked receptors.
However, in the hippocampus, stimulation of Gi-coupled
receptors potentiates Gs-stimulated cAMP levels. This
effect may be associated with the regulatory properties of adenylyl
cyclase types 2 and 4 (AC2 and AC4), isoforms that are potentiated by
the  subunit of Gi in vitro. Although AC2 has been shown to be stimulated by  in whole cells, reports describing the sensitivity of AC4 to  in vivo have
yet to emerge. Our results demonstrate that Gs-mediated
stimulation of AC4 is potentiated by  released from activated
Gi-coupled receptors in intact human embryonic kidney
(HEK) 293 cells. Furthermore, we show that the AC2 and AC4
proteins are expressed in the mouse hippocampal formation and that they
colocalize with MAP2, a dendritic and/or postsynaptic marker. The
presence of AC2 and AC4 in the hippocampus and the ability of each of
these enzymes to detect coincident activation of Gs- and
Gi-coupled receptors suggest that they may play a crucial
role in certain forms of synaptic plasticity by coordinating such
overlapping synaptic inputs.
Key words:
adenylyl cyclase; cAMP; G-protein;  ; hippocampus; synaptic plasticity; immunohistochemistry; immunocytochemistry
 |
INTRODUCTION |
The regulation of adenylyl cyclases
by G-protein-coupled receptors is a classically described mechanism in
which a stimulatory G-protein (Gs) couples
neurotransmitters to activation of adenylyl cyclase, whereas an
inhibitory G-protein (Gi) couples to inhibition of
adenylyl cyclase. In certain tissues, Gi signaling can
potentiate Gs input (Andrade, 1993 ; Gereau and Conn, 1994 ;
Pian and Dobbs, 1995 ; Olianas et al., 1998 ). Specifically,
norepinephrine- or isoproterenol-induced increases in cAMP are enhanced
by activation of Gi-coupled 5-HT1A or
GABAB receptors (Andrade, 1993 ).
Although the Ca2+-stimulated adenylyl cyclases (AC1
and AC8) are believed to play a role in synaptic plasticity in the
hippocampus (Choi et al., 1993 ; Weisskopf et al., 1994 ; Wu et al.,
1995 ; Xia et al., 1995 ; Villacres et al., 1998 ), other isoforms may
also be necessary. For example, at the mossy fiber (mf)-CA3 synapse, long-term potentiation (LTP) is dependent on opioid neurotransmission (Williams and Johnston, 1996 ). Opioid receptors are coupled to Gi/Go, and pertussis toxin
treatment prevents the development of LTP at this synapse (Ito et al.,
1988 ). In addition, elevation of cAMP is required for mf-CA3 LTP
(Huang et al., 1994 , 1995 ; Weisskopf et al., 1994 ) as well as for
long-lasting LTP in area CA1 (Frey et al., 1993 ). Pertussis
toxin treatment has also been demonstrated to prevent the formation of
LTP in area CA1 (Goh and Pennefather, 1989 , 1990 ).
To date, nine mammalian adenylyl cyclase isotypes (AC1-AC9) have been
identified (Krupinski et al., 1989 ; Bakalyar and Reed, 1990 ; Feinstein
et al., 1991 ; Gao and Gilman, 1991 ; Ishikawa et al., 1992 ; Katsushika
et al., 1992 ; Premont et al., 1992 , 1996 ; Yoshimura and Cooper, 1992 ;
Cali et al., 1994 ; Hellevuo et al., 1995 ). Each is distributed and
regulated uniquely (Choi et al., 1993 ; Iyengar, 1993 ; Cooper et al.,
1995 ; Taussig and Gilman, 1995 ; Xia et al., 1995 ; Sunahara et al.,
1996 ). mRNA has been detected for AC1 (Xia et al., 1991 ), AC2 (Furuyama
et al., 1993 ), AC3 (Glatt and Snyder, 1993 ), AC8 (Cali et al., 1994 ),
and AC9 (Premont et al., 1996 ) in the mammalian hippocampus.
The in vitro regulatory properties of AC2 and AC4 are
consistent with the possibility of a role in Gi-mediated
potentiation of Gs-stimulated cAMP. The activity of both
isoforms is potentiated in vitro by Gi in the
presence of Gs (Feinstein et al., 1991 ; Gao and Gilman,
1991 ; Lustig et al., 1993 ). Whereas AC2 has been characterized
extensively in intact cells (Federman et al., 1992 ; Jacobowitz et al.,
1993 ; Lustig et al., 1993 ; Tsu and Wong, 1996 ), in vivo
regulatory properties of AC4 have not been defined. Furthermore, it is
not known whether either of the  -stimulated adenylyl cyclase proteins is expressed in the hippocampus. To assess whether AC2 and/or
AC4 could be involved in the control of hippocampal cAMP levels, we
determined the immunohistochemical localization of AC2 and AC4 proteins
in the mouse hippocampus and characterized the regulation of AC4 in
human embryonic kidney (HEK) 293 cells. Our findings suggest that the
presence of AC2 and/or AC4 in the hippocampus may account for some of
the electrophysiological and biochemical effects of coincident
Gs- and Gi-coupled receptor activation
(Andrade, 1993 ; Gereau and Conn, 1994 ).
 |
MATERIALS AND METHODS |
Materials. Isoproterenol, 3-methyl-1-isobutylxanthine
(IBMX), serotonin, and somatostatin-14 were purchased from Sigma (St. Louis, MO). Pertussis toxin was obtained from List Biologic (Campbell, CA). Restriction endonucleases and DNA ligase were purchased from New
England Biolabs (Beverly, MA). Polyclonal antibodies generated against
adenylyl cyclases 2 or 4 were generously provided by Santa Cruz
Biotechnology (Santa Cruz, CA). Monoclonal antibodies generated against
MAP-2 or synaptophysin were purchased from Sigma.
Cell culture. HEK 293 cells were grown at 37°C in
HEPES-buffered (H)-DMEM supplemented with 10% bovine calf serum
(BCS) and 1% penicillin and streptomycin in a humidified 95%
O2/5% CO2 incubator. Cell culture
materials were obtained from Life Technologies (Gaithersburg, MD)
unless otherwise indicated.
Expression of the 5-HT7A receptor and AC2 or AC4 in
HEK 293 cells. The AC4 cDNA clone was generously provided by Drs.
Wei-Jen Tang and Alfred G. Gilman (University of Texas Southwestern
Medical Center, Dallas, TX). The AC4 insert was released from
pBluescript (Stratagene, La Jolla, CA) by digestion with
KpnI and BamHI and was ligated into the pCEP4
expression vector (Invitrogen, San Diego, CA). The AC2 cDNA was
generously provided by Dr. Randall R. Reed (Johns Hopkins School of
Medicine, Baltimore, MD) and was ligated into pCEP4. The
5-HT7A receptor cDNA clone was a gift from Dr. Mark Hamblin
(Veterans Administration Medical Center, Seattle, WA) and was ligated
into pcDNAIII (Invitrogen). Polyclonal populations of G418- (500 µg/ml; Calbiochem, La Jolla, CA) and/or hygromycin- (400 µg/ml;
Calbiochem) resistant 293 cells were obtained by stable transfection of
the pcDNAIII or pCEP4 expression vector and/or
pcDNAIII-5-HT7A or pCEP4-AC4 (or pCEP4-AC2 alone for
analysis of AC2 expression by immunocytochemistry) using the calcium
phosphate method (Chen and Okayama, 1987 ). All stable cell lines were
created from the same parental population of HEK 293 cells. Expression of 5-HT7A or exogenous adenylyl cyclases was determined by
cAMP accumulation assays as described below.
cAMP accumulation assay. Changes in intracellular cAMP were
measured by determining the ratio of [3H]cAMP to
the total ATP, ADP, and AMP pool in
[3H]adenine-loaded cells as described previously
(Wong et al., 1991 ). This assay system allows for rapid and sensitive
determination of relative changes in intracellular cAMP. Although the
ratios measured between assays generally vary somewhat, the relative change in cAMP observed between assays is very reproducible. In brief,
as cells in 12-well plates approached confluency, they were incubated
in H-DMEM plus 10% BCS containing 2 µCi of
[3H]adenine (ICN Biochemicals, Costa Mesa, CA) per
well for 16-20 hr. The next day, the labeling medium was aspirated,
and the cells were washed once with 150 mM NaCl and
incubated in H-DMEM plus 1% penicillin and streptomycin containing the
indicated effectors (e.g., isoproterenol, serotonin, and somatostatin)
plus 1 mM IBMX for 30 min. Reactions were terminated by
aspiration of the medium and addition of 1 ml of ice-cold 5%
trichloroacetic acid plus 1 µM cAMP. Culture dishes were
maintained at 4°C for 1-4 hr, and acid-soluble nucleotides were
separated by sequential Dowex AG50WX-4 and neutral alumina
chromatography as described previously (Salomon et al., 1974 ). The data
are reported as the average of triplicate determinations. Pertussis
toxin, when used, was added to cells during the
[3H]adenine-labeling period for 16-20 hr.
Transient coexpression of AC4 with the C terminal of
-adrenergic receptor kinase 1 or transducin in HEK 293 cells. The peptide minigene construct encoding the C terminal of
-adrenergic receptor kinase 1 ( ARK1-ct,
denoted the "PH domain" for pleckstrin homology domain) in the pRK5
plasmid (Koch et al., 1994 ) was generously provided by Dr. Robert
Lefkowitz (Duke University Medical Center, Durham, NC). A cDNA clone
for the subunit of human rod transducin (denoted
Gt) was provided by Dr. Neil M. Nathanson
(University of Washington, Seattle, WA). Briefly, the night before
transfection, cells were plated onto 100 mm plates at a density of
~70%. The following morning, each plate was transfected with 8 µg
of total DNA [1 µg of 5-HT7A, 2.5 µg of pCEP4
or pCEP4-AC4, 4 µg of pCDNAIII, pCDNAIII-transducin , or
pRK- ARK1-ct, and 0.5 µg of Rous sarcoma virus
(RSV)- -galactosidase] in H-DMEM in the presence of 50-60 µl of Lipofectamine (Life Technologies). After 5 hr, cells were rinsed with H-DMEM plus 1% penicillin and streptomycin and 10% BCS
and were maintained for 24 hr. The following day, cells were split and
seeded onto 12-well culture dishes (one transfected plate per 12-well
dish) for cAMP assays as well as onto 12-well plates (two wells per
transfection) for -galactosidase assays (see below). The next
morning, cells used for cAMP assays were labeled for 4-6 hr with 2-3
µCi of [3H]adenine (ICN) per well. Just
before the cAMP assay, companion cells for the -galactosidase assays
were lysed and harvested in 500 µl of buffer B (100 mM
KH2PO4, pH 7.8, 0.2% Triton X-100, and
1 mM DTT) and frozen until use. cAMP and -galactosidase
assays were performed as described, and all data were normalized to the measured -galactosidase signal for each transfection.
-Galactosidase assay. Lysates from transiently
transfected cells were thawed and centrifuged at 16,000 × g for 10 min. The supernatant (20 µl) was combined with
100 µl of reaction buffer [100 mM
Na2HPO4, pH 8.0, 1 mM
MgCl2, 35 mM Galacton (Tropix, Bedford, MA), and 100 mM D-galactose] and incubated in
the dark at room temperature for 60 min. During the incubation period,
a 10% solution of Emerald (Tropix) in 0.2N NaOH was prepared for
subsequent addition to the samples at 5 sec intervals by a Berthold
luminometer. Each well of lysed cells was assayed in duplicate, and the
data were used to normalize for transfection efficiency.
Description of AC2 and AC4 antibodies. The anti-AC2 and -AC4
antibodies generated by Santa Cruz Biotechnology are rabbit polyclonal antibodies generated against 20 amino acid peptides corresponding to
unique intracellular C-terminal amino acid sequences in AC2 and AC4,
respectively. The sequence used to generate the AC2 antibody corresponds to amino acids 1071-1090 (KTYFVNTEMSRSLSQSNLAS) of rat
AC2, which is 95% identical to the corresponding human sequence. The
sequence used to generate the AC4 antibody corresponds to amino acids
1045-1064 (QLCTYFLNTDLTRTGSPSAS) of rat AC4. Database searches using
GCG Blast revealed high-score matches only to rat and human AC2 for the
AC2 antigen peptide and to rat AC4 for the AC4 antigen peptide.
Western blot analysis of AC2 and AC4 expression in HEK 293 cells. HEK 293 cells expressing the pCEP4 vector alone or cells stably transfected with AC2 or AC4 were grown to confluence in 100 mm
culture dishes and harvested in 20 mM Tris HCl, pH
7.4, 1 mM EDTA, 2 mM MgCl2,
0.5 mM DTT, 0.5 mM PMSF, 3.2 µg/ml leupeptin, 2 µg/ml aprotinin, and 0.5 µg/ml pepstatin A. Homogenates were centrifuged at 600 × g for 5 min, and the supernatant
was retained and centrifuged at 90,000 × g for 30 min.
Membrane pellets were resuspended in buffer C (1% NP-40, 50 mM sodium phosphate, pH 7.4, 10 mM EDTA, 1 mM DTT, 2 mM MgCl2, 0.5 mM PMSF, 5 µg/ml leupeptin, and 2 µg/ml aprotinin) and
were used immediately or frozen at 80°C for later use. Protein
concentrations were determined according to the method of Bradford,
using BSA as a standard (Bradford, 1976 ). Some AC4 samples were
subjected to deglycosylation by N-glycosidase F (Boehringer Mannheim,
Indianapolis, IN) before electrophoresis. Twenty microgram samples were
resuspended in buffer C, SDS was added to 0.1%, and samples were
heated at 95°C for 5 min. Samples were deglycosylated with 0.5 units
of N-glycosidase F for 1 hr at 37°C. The deglycosylation reaction was
terminated by addition of Laemmli buffer (Laemmli, 1970 ). Proteins were
separated by native PAGE (for AC2) or SDS-PAGE (for AC4) on 7.5%
acrylamide gels and were subsequently transferred to a polyvinylidene
difluoride membrane (AC2) or nitrocellulose (AC4) and blocked with 3%
cold fish gelatin (Sigma) in 20 mM Tris HCl, pH 7.4, 150 mM NaCl, and 0.05% Tween 20 for 1-2 hr at room
temperature. Blots were incubated with 100 ng/ml anti-AC2 or -AC4 at
4°C for 16-20 hr followed by HRP-conjugated goat anti-rabbit IgG for
1 hr. Blots were developed by enhanced chemiluminescence (Amersham,
Arlington Heights, IL) according to the manufacturer's guidelines.
HEK 293 cell immunocytochemistry. HEK 293 cells alone or
stably transfected with AC2 or AC4 were plated onto
poly-D-lysine-coated coverslips (60 µg/ml
poly-D-lysine) and grown in appropriate growth medium for
2-4 d. Cells were fixed with 4% paraformaldehyde in PBS, pH 7.4, for
20 min, rinsed with PBS, and permeabilized and blocked for 1 hr with
PBS plus 0.5% Triton X-100, 4% cold fish gelatin, and 1% normal goat
serum. Cells were incubated with 100 ng/ml anti-AC2 or -AC4 in PBS plus
0.5% cold fish gelatin overnight at 4°C on a rocker, rinsed, and
then incubated with 1 µg/ml lissamine-rhodamine-conjugated goat
anti-rabbit IgG for 1 hr. After a final rinse, the coverslips were
mounted onto slides with Gelmount (Biomedia, Foster City, CA). Where
indicated, peptide antigen specific for AC2 or AC4 (Santa Cruz
Biotechnology) was included at a 20-fold molar excess to antibody as a control.
Immunohistochemistry on mouse hippocampal sections. C57Bl/6J
mice were killed by decapitation, and the brains were quickly removed.
Coronal brain slices (500 µm) were cut using a vibratome (Campden
Instruments, Leicestershire, UK). Slices were fixed for 4-6 hr with
4% paraformaldehyde in PBS, pH 7.4. After fixation, slices were
cryoprotected in PBS plus 30% sucrose and 0.02% NaN3 and were maintained at 4°C until further use. For immunolabeling, 40 µm sections were cut from the fixed 500 µm slices on a sliding microtome and placed free-floating into a blocking solution of PBS, pH
7.4, plus 0.025% Triton X-100 (PBST) supplemented with 5% BSA.
Sections were blocked for 1 hr at room temperature and then incubated
in PBST plus 0.5% BSA and 250 or 125 ng/ml rabbit polyclonal antibody
against AC2 or AC4, respectively, for 18-24 hr. Where indicated,
peptide antigens were added at a 20-fold molar excess to antibody
immediately before incubation. After incubation with the primary
antibody, sections were washed four times for 10 min in PBST at room
temperature, after which 1 µg/ml lissamine-rhodamine-conjugated goat
anti-rabbit IgG (Jackson ImmunoResearch, West Grove, PA) was added
to the sections for 1 hr at room temperature. Sections were then
washed and mounted onto slides using Gelmount (Biomedia) or
Vectashield (Vector Laboratories, Burlingame, CA). For double labeling,
a 1 hr incubation in a 1:400 dilution of mouse monoclonal
anti-synaptophysin (clone SVP-38, ascites fluid; Sigma) or a 1:500
dilution of mouse monoclonal anti-MAP2 (clone HM-2, ascites fluid;
Sigma) was followed by incubation in 1 µg/ml FITC-conjugated goat
anti-mouse antibody (Jackson ImmunoResearch). Immunolabeling was
analyzed using a Bio-Rad MRC 600 confocal microscope (William M. Keck
Imaging Center, University of Washington, Seattle, WA). Labeling of
discrete brain structures was determined according to the mouse brain
atlas of Franklin and Paxinos (1997) . Images were processed
using Adobe Photoshop 4.0.
 |
RESULTS |
G-protein-coupled receptors stimulate AC4 in intact cells
HEK 293 cells were transfected with AC4 cDNA, and cells from the
stably selected polyclonal cell line were treated with the -adrenergic agonist isoproterenol. HEK 293 cells express endogenous -adrenergic receptors that couple to stimulation of adenylyl cyclase
via Gs (Impey et al., 1994 ; Wayman et al., 1994 , 1995 ). Isoproterenol increased cAMP with an EC50 value of ~200
nM. Maximal stimulation occurred at 1 µM
(Fig. 1A). The sharp
isoproterenol dose-response curve may reflect isoproterenol oxidation,
yielding a threshold effect at 1 µM isoproterenol. cAMP
was also measured in response to serotonin in 293-AC4 cells stably
coexpressing the Gs-coupled 5-HT7A receptor
(Shen et al., 1993 ). cAMP accumulation in nontransfected cells was
subtracted from the 293-AC4 value. Serotonin increased cAMP with an
EC50 value of ~8 nM and with maximal
stimulation at 250 nM serotonin (Fig.
1B). The extended dose-response curve for 5-HT was
observed consistently and may be attributable to differential
properties of overexpressed transfected (5-HT7A)
versus endogenous ( -adrenergic) receptors. These data demonstrate
that AC4 is stimulated by activation of Gs-coupled receptors in vivo.

View larger version (15K):
[in this window]
[in a new window]
|
Figure 1.
Gs-coupled receptors stimulate AC4 in
HEK 293 cells. A, HEK 293 cells stably expressing AC4
were treated with increasing concentrations of isoproterenol.
B, HEK 293 cells stably coexpressing AC4 with the
Gs-coupled 5-HT7 receptor were treated with
increasing concentrations of serotonin. Relative cAMP accumulation was
determined as described in Materials and Methods, and endogenous HEK
293 cell cAMP accumulation was subtracted from the cAMP measured in
AC4-expressing cells. The data are the means ± SD of triplicate
assays.
|
|
Gi-mediated potentiation is inhibited by
pertussis toxin and by  -binding peptides
G-protein  subunits potentiate Gs stimulation
of AC2 (Tang and Gilman, 1991 ) and AC4 (Gao and Gilman, 1991 ) in
vitro. To determine whether Gi stimulates AC4 in
vivo, we treated HEK 293 cells expressing AC4 with somatostatin in
the presence or absence of pertussis toxin. Endogenous somatostatin
receptors expressed in HEK 293 cells activate Gi and
inhibit adenylyl cyclases (Nielsen et al., 1996 ). Pertussis toxin
catalyzes the ADP-ribosylation of the
Gi/Go class of G-proteins (Katada and
Ui, 1982 ; Burns et al., 1983 ; Hsia et al., 1984 ; Neer et al., 1984 )
leading to uncoupling of the receptor and Gi (West et al.,
1985 ). Recognition of the heterotrimer and ADP-ribosylation of the subunit prevent the subsequent release of the  subunit (for
review, see Gierschik, 1992 ). In cells not treated with pertussis
toxin, isoproterenol stimulated AC4 threefold. Somatostatin alone
induced a slight inhibition of basal activity and did not stimulate
AC4. However, coapplication of isoproterenol and somatostatin produced
a synergistic increase in cAMP over that observed in response to
isoproterenol alone (Fig.
2A). Pertussis toxin
treatment increased basal activity, and the somatostatin potentiation
of isoproterenol-stimulated cAMP was completely blocked (Fig.
2A). These results indicate that somatostatin
enhancement of AC4 activation is caused by Gi.

View larger version (20K):
[in this window]
[in a new window]
|
Figure 2.
Pertussis toxin, ARK1 PH domain
peptide expression, and transducin (Gt)
expression block Gi-coupled receptor potentiation of
Gs-stimulated AC4. A, HEK 293 cells stably
expressing AC4 were incubated overnight with vehicle
( PTx) or 200 ng/ml pertussis toxin
(+PTx). The following day, cells were treated with
vehicle or 10 µM isoproterenol (iso) in
the presence or absence of 500 nM somatostatin
(som). Relative cAMP accumulation was determined as
described in Materials and Methods. The data are the means ± SD
of triplicate assays. B, HEK 293 cells were transiently
transfected with RSV- -galactosidase and the 5-HT7A
receptor, along with either pCDNAIII or the ARK1 PH
domain and either pCEP4 or pCEP4-AC4 as described in Materials and
Methods. Cells transfected with the ARK1 PH domain are
denoted PH domain. AC4-transfected cells with or without the PH domain
were treated with 10 µM serotonin in the presence or
absence of 500 nM somatostatin. 5-HT-stimulated activity
did not differ significantly between AC4-transfected and AC4- and PH
domain-transfected cells; the ratio value for AC4 cells in response to
5-HT alone was 2.088 ± 0.389 and for AC4 and PH domain cells was
3.565 ± 0.688. C, Cells were transiently
transfected with RSV- -galactosidase and the 5-HT7A
receptor, along with either pCDNAIII or transducin and either pCEP4
or pCEP4-AC4 as described in Materials and Methods. Cells transfected
with transducin are denoted Gt. Cells were treated
with 1 µM serotonin in the presence or absence of 500 nM somatostatin. 5-HT-stimulated activity did not differ
significantly between AC4-transfected and AC4- and Gt-transfected
cells; the ratio value for AC4 cells in response to 5-HT alone was
0.630 ± 0.292 and for AC4 and Gt cells was 0.622 ± 0.091. For
B and C, relative cAMP accumulation was
determined as described in Materials and Methods. The data are
expressed as percent cAMP accumulation in the absence of somatostatin,
with this level being set as 100%. The fold stimulation over the
basal activity was similar between transfections with or without
the PH domain or transducin . The data are the means ± SD of
triplicate assays and were subtracted for endogenous
(pCEP4-transfectant) cAMP accumulation and corrected for transfection
efficiency using -galactosidase.
|
|
To determine whether somatostatin increases AC4 activity by stimulating
the release of  from Gi, we performed
transient transfections of HEK 293 cells in which the
Gs-coupled 5-HT7A receptor and AC4 were
cotransfected with a construct encoding the  -binding, C-terminal
region of -adrenergic receptor kinase 1 (referred to here as the
pleckstrin homology or PH domain). Cellular expression of this PH
domain can attenuate the effect of  on the MAP kinase pathway and
phospholipase C (Inglese et al., 1994 ; Koch et al., 1994 ; Luttrell et
al., 1995 ). In cells transfected with 5-HT7A, AC4,
and the empty vector for the PH domain, somatostatin potentiated
serotonin stimulation of AC4 by ~80% (Fig. 2B).
When the PH domain was coexpressed, somatostatin potentiation of
Gs-stimulated AC4 was completely abolished (Fig. 2B). Similar results were obtained using a
cotransfected using a cotransfected transducin subunit as a 
scavenger. Coexpression of transducin (Gt) with
AC4 and the 5-HT7A receptor inhibited somatostatin-mediated
potentiation of serotonin-induced cAMP levels (Fig. 2C).
These data suggest that somatostatin stimulation of Gs-activated AC4 activity is caused by  release from
Gi.
Characterization of AC2 and AC4 antibodies in HEK 293 cells
Before determining the expression of AC2 and AC4 in the
hippocampus, we characterized the specificity of the AC2 and AC4
polyclonal antibodies by Western blot and immunolabeling studies. By
Western blot, the AC2 antibody recognized AC2 overexpressed in HEK 293 cells under native conditions and very little under denaturing conditions (Fig. 3A). HEK 293 cells express low levels of AC2 endogenously (Hellevuo et al., 1993 ).
Accordingly the AC2 antibody also recognized a low level of AC2 in
nontransfected cells (Fig. 3A). The specificity of the AC4
antibody was also analyzed by Western blot (Fig. 3B).
Untransfected HEK 293 cells showed no immunoreactive bands, whereas
cells overexpressing AC4 showed bands at ~110 and 150 kDa. Treatment
with N-glycosidase F shifted the 150 kDa band to the lower molecular
weight, indicating that the lower band corresponds to non- or
subglycosylated AC4. A minor band detected at ~60 kDa was observed in
AC4-expressing cells only and is likely a proteolytic fragment of AC4
that is also recognized by the AC4 antibody.

View larger version (42K):
[in this window]
[in a new window]
|
Figure 3.
Western blot detection of AC2 and AC4 in HEK 293 cell membranes. A, Whole-cell lysate from HEK 293 cells
expressing the pCEP4 vector alone (293) or AC2-pCEP4
(293-AC2) was subjected to native PAGE conditions and
Western blotted as described in Materials and Methods. Blots were
developed using enhanced chemiluminescence and scanned on a
Hewlett-Packard Scan Jet II CX scanner. B,
Membranes from HEK 293 cells were prepared and treated with or without
N-glycosidase F as described in Materials and Methods. Twenty
micrograms of membranes from 293-pCEP4 cells (293;
lanes 1 and 2) and 293-AC4 cells
(293-AC4; lanes 3 and
4) were separated by SDS-PAGE on 7.5% acrylamide
gels. Protein was transferred to nitrocellulose and incubated with
anti-AC4 antibody. Molecular weight markers equal 206, 117, 89, and 47 kDa. Note the conversion of the glycosylated form(s) to the lower
molecular weight nonglycosylated form after treatment with
N-glycosidase F. A minor band at ~60 kDa is only seen in
AC4-expressing cells and is therefore probably a proteolytic fragment
of AC4 that is recognized by the AC4 antibody.
|
|
Immunolabeling studies using untransfected HEK 293 cells or cells
expressing AC2 or AC4 were also performed (Fig.
4). The AC2 antibody produced a low level
of labeling in HEK 293 cells transfected with the empty expression
vector (Fig. 4A). In contrast, pronounced membrane
labeling was observed in cells stably expressing AC2 (Fig.
4B), which was completely abrogated after AC2 peptide adsorption (Fig. 4C). No AC2 labeling over endogenous levels
was observed in AC4-expressing cells (Fig. 4D).
Similarly, the AC4 antibody labeled cells expressing AC4 (Fig.
4F) but not vector-transfected cells (Fig.
4E) or cells expressing AC2 (Fig.
4H). Adsorption of the AC4 antibody with the AC4
peptide blocked all immunolabeling with the AC4 antibody (Fig.
4G). The AC2 and AC4 antibodies also did not recognize other
adenylyl cyclases (AC1, AC3, AC5, AC6, AC8, and AC9) expressed in HEK
293 cells (data not shown).

View larger version (66K):
[in this window]
[in a new window]
|
Figure 4.
Immunocytochemical detection of AC2 and
AC4 stably expressed in HEK 293 cells. A,
E, HEK 293 cells transfected with the pCEP4 vector
(designated HEK 293) were processed for
immunocytochemistry with the AC2 (A) or AC4
(E) antibody as described in Materials and
Methods. B, F, HEK 293 cells expressing
AC2 or AC4 (designated 293-AC2 or
293-AC4) were labeled with the AC2
(B) or AC4 (F) antibody.
C, Adsorption of the AC2 antibody with AC2 peptide
antigen (PEP) blocked AC2 immunolabeling in HEK 293 cells
expressing AC2. D, Cells expressing AC4 did not label
with the AC2 antibody. G, Adsorption of the AC4 antibody
with AC4 peptide antigen blocked AC4 immunolabeling in HEK 293 cells
expressing AC4. H, Cells expressing AC2 did not label
with the AC4 antibody. Scale bar, 25 µm.
|
|
Analysis of AC2 and AC4 expression in mouse
hippocampal formation
To define the expression and localization of AC2 and AC4 proteins
in the mouse hippocampal formation, we performed immunhistochemical studies. The AC4 antibody was also used to immunoprecipitate AC4 from
mouse hippocampal membranes (data not shown). The AC2 antibody was not
useful for immunoprecipitation. For immunohistochemistry, 40 µm
hippocampal slices were labeled using either the AC2 or AC4 antibody
and were examined by confocal microscopy. Specific labeling for both
adenylyl cyclase isoforms was observed throughout the hippocampal
formation, and the labeling pattern was more or less indistinguishable
for both AC2 and AC4. In the dentate gyrus, immunolabeling for AC2 and
AC4 was concentrated in the proximal dendrites of the granule cells and
extended into the dendritic field in the molecular layer (Fig.
5A,B).
A lower level of labeling was also observed in the cell bodies. Double
labeling was performed for AC2 or AC4 and either a dendritic marker
(MAP2; Figs. 6,
7) or a synaptic terminal marker
(synaptophysin; Figs. 8,
9). AC signal was coincident with the
MAP2 labeling in the dendrites (Fig.
6C,F,C',F';
yellow indicates coincident signal) and did not colocalize
at all with the synaptophysin signal (Fig. 8), indicating a
postsynaptic localization of these adenylyl cyclase isoforms. Scattered
cells in the hilus were also labeled using the AC2 and AC4
antibodies.

View larger version (156K):
[in this window]
[in a new window]
|
Figure 5.
Immunohistochemical detection of AC2 and AC4 in
the mouse hippocampal formation. Mouse brain sections (40 µm) were
processed for immunohistochemistry as described in Materials and
Methods. A, AC2 labeling in the dentate gyrus
(DG). B, AC4 labeling in dentate gyrus.
Note the concentration of AC2 and AC4 label in the proximal dendrites
(arrows) and into the dendritic field in the molecular
layer (arrowheads). C, AC2 labeling in
area CA3. D, AC4 labeling in area CA3. Note the
concentration of labeling in the CA3 neuron dendrites in the stratum
lucidum (the dendrites are viewed in the coronal plane in these tissue
sections). The boxed areas in C and
D show specific examples of the described labeling pattern.
E, AC2 labeling in area CA1. F, AC4
labeling in area CA1. Note the accumulation of label in the CA1 cell
bodies and along the membrane of the CA1 dendrites
(arrows) in the stratum radiatum. HIL,
Hilus; LUC, stratum lucidum; STR RAD,
stratum radiatum. Scale bar, 10 µm.
|
|

View larger version (91K):
[in this window]
[in a new window]
|
Figure 6.
Top. Immunohistochemical detection of
AC2 and AC4 in the mouse dentate gyrus. Mouse brain sections (40 µm)
were processed for immunohistochemistry as described in Materials and
Methods. A, AC2 labeling (red).
B, MAP2 labeling of the same image shown in
A (green). C,
Merged image of A and B
(yellow indicates coincident localization).
D, AC4 labeling (red).
E, MAP2 labeling of the same image shown in
D (green). F,
Merged image of D and E
(yellow as described in C).
C', F', Higher magnification images of
the boxed areas in C and
F, respectively. Scale bar, 50 µm. Boxed
areas in A and B correspond to that in
C. Boxed areas in D and
E correspond to that in F.
Figure 7.
Bottom. Immunohistochemical
detection of AC2 and AC4 in the CA1 region of mouse hippocampus. Mouse
brain sections (40 µm) were processed for immunohistochemistry as
described in Materials and Methods. A, AC2 labeling
(red). B, MAP2 labeling of the same image
shown in A (green).
C, Merged image of A and B
(yellow indicates coincident localization).
D, AC4 labeling (red). E,
MAP2 labeling of the same image shown in D
(green). F, Merged image of
D and E (yellow as
described in C). C', F',
Higher magnification images of the boxed areas in
C and F, respectively. Scale bar, 50 µm. Boxed areas in A and B
correspond to that in C. Boxed areas in
D and E correspond to that in F.
|
|

View larger version (84K):
[in this window]
[in a new window]
|
Figure 8.
Top. Immunohistochemical localization of
AC2 and AC4 relative to synaptophysin in the mouse dentate gyrus. Mouse
brain sections (40 µm) were processed for immunohistochemistry as
described in Materials and Methods. A, AC2 labeling.
B, Synaptophysin (Syn) labeling of the
same image shown in A. Note that the labeling pattern
for AC2 is not coincident with that for synaptophysin.
C, Peptide adsorption of AC2 eliminating AC2 labeling in
the dentate gyrus. D, AC4 labeling. E,
Synaptophysin labeling of the same image shown in D.
Note that the labeling pattern for AC4 is not coincident
with that for synaptophysin. F, Peptide adsorption of
AC4 eliminating AC4 labeling in the dentate gyrus. Scale bar, 50 µm.
Figure 9.
Bottom. Immunohistochemical
localization of AC2 and AC4 relative to synaptophysin in the CA1 region
of the mouse hippocampus. Mouse brain sections (40 µm) were processed
for immunohistochemistry as described in Materials and Methods.
A, AC2 labeling. B, Synaptophysin
labeling of the same image shown in A. Note that the
labeling pattern for AC2 is not coincident with that for synaptophysin.
C, Peptide adsorption of AC2 eliminating AC2 labeling in
CA1. D, AC4 labeling. E, Synaptophysin
labeling of the same image shown in D. Note that the
labeling pattern for AC4 is not coincident with that for synaptophysin.
F, Peptide adsorption of AC4 eliminating AC4 labeling in
CA1. Scale bar, 50 µm.
|
|
In area CA3, labeling for both AC2 and AC4 was concentrated in short,
coronally sectioned CA3 pyramidal cell dendrites throughout the stratum
lucidum (Fig. 5C,D). Upon closer examination, the labeling was coincident with MAP2 signal (Fig.
10C,F,C',F').
Similar to the pattern observed in the dentate gyrus, the labeling
pattern was not colocalized with synaptophysin signal (Fig.
11C,F,C',F'). In fact, the adenylyl cyclase label appeared in many instances to be
surrounded by synaptophysin labeling, similar to what has been
described (Lim et al., 1997 ) where several mossy fiber synaptic terminals or a single large terminal impinge on a given dendritic region. There was very little labeling for AC2 or AC4 in the CA3 pyramidal cell bodies.

View larger version (88K):
[in this window]
[in a new window]
|
Figure 10.
Top. Immunohistochemical localization
of AC2 and AC4 with MAP2 in the CA3 region of the mouse hippocampus.
Mouse brain sections (40 µm) were processed for immunohistochemistry
as described in Materials and Methods. A, AC2 labeling
(red). B, MAP2 labeling of the same image
shown in A (green).
C, Merged image of A and B
(yellow indicates coincident localization of AC2
and MAP2). D, AC4 labeling (red).
E, MAP2 labeling of the same image shown in
D (green). F,
Merged image of D and E
(yellow as described in C).
C', F', Higher magnification images of
the boxed areas in C and
F, respectively. Scale bar, 50 µm. Boxed
areas in A and B correspond to that in
C. Boxed areas in D and E
correspond to that in F.
Figure 11.
Bottom. Immunohistochemical
localization of AC2 and AC4 with synaptophysin in the CA3 region of
mouse hippocampus. Mouse brain sections (40 µm) were processed for
immunohistochemistry as described in Materials and Methods.
A, AC2 labeling (red). B,
Synaptophysin labeling of the same image shown in A
(green). C, Merged image of
A and B (note lack of
yellow labeling, indicating a lack of coincident
localization of AC2 and synaptophysin). D, AC4 labeling
(red). E, Synaptophysin labeling of the
same image shown in D (green).
F, Merged image of D and
E. C', F', Higher
magnification images of the boxed areas in
C and F, respectively. Scale bar, 50 µm. Boxed areas in A and B
correspond to that in C. Boxed areas in
D and E correspond to that in F.
|
|
In area CA1, immunofluorescence for both AC2 and AC4 was concentrated
along the apical dendrites throughout the stratum radiatum, with some
labeling in the CA1 pyramidal cell bodies as well (Fig. 5E,F). As with the labeling
in the dentate gyrus and CA3, the signal was coincident with the signal
for the postsynaptic marker MAP2 (Fig.
7C,F,C',F')
and was not colocalized with labeling for synaptophysin (Fig. 9). Very
little labeling was seen in the processes in the stratum oriens,
although occasional small cell bodies did label for AC2 or AC4. The
labeling for AC2 and AC4 throughout the hippocampal formation was
completely blocked by adsorption with the appropriate peptide antigen
(Figs. 8C,F, 9C,F).
Double labeling for AC2 and AC4 in the same tissue sections using a
combination of fluorophore-labeled IgG and Fab fragments demonstrated
that AC2 and AC4 are expressed in a very similar manner in the mouse hippocampal formation (data not shown). The only consistent difference in labeling was a slightly higher level of AC2 over AC4 signal in the
dentate gyrus granule somas (Fig.
5A,B).
Immunohistochemical labeling for AC4 was also observed in several
forebrain regions. In the neocortex and piriform cortex, a moderate
percentage of neurons were labeled and included pyramidal cell bodies
and dendrites (data not shown). Discrete labeling of neurons in the
septum, medial habenular nucleus, induseum griseum, and the
paraventricular thalamic nucleus was also seen (data not shown).
 |
DISCUSSION |
Each of the adenylyl cyclase isoforms possesses distinct
regulatory properties, and all of the cloned mammalian adenylyl
cyclases are expressed in the brain. Therefore, cAMP levels in neurons can be modulated by a variety of signals, including receptor
activation, changes in intracellular Ca2+, and
activation of protein kinases (for review, see Sunahara et al., 1996 ).
Of particular interest are adenylyl cyclases that integrate coincident
signals from different upstream pathways. For example, AC1 is
synergistically stimulated by Gs-coupled receptors and
Ca2+ (Impey et al., 1994 ; Wayman et al., 1994 ) and
contributes to mossy fiber-CA3 LTP (Villacres et al., 1998 ). Other
examples include the  -stimulated adenylyl cyclases, which are
synergistically activated by Gs-coupled receptors and
 released from Gi-coupled receptors.
Whereas most mammalian tissues express adenylyl cyclase activity that
is inhibited by activation of Gi-coupled receptors, in the
brain and lung, Gi-coupled receptors actually potentiate Gs-stimulated cAMP production (Andrade, 1993 ; Gereau and
Conn, 1994 ; Pian and Dobbs, 1995 ; Olianas et al., 1998 ). In the
hippocampus, in particular, several groups have observed potentiation
of Gs-coupled receptor stimulation by
Gi-coupled receptors (Andrade, 1993 ; Gereau and Conn,
1994 ). The Ca2+-stimulated adenylyl cyclases (AC1
and AC8) are thought to play a role in synaptic plasticity in the
hippocampus (Choi et al., 1993 ; Weisskopf et al., 1994 ; Wu et al.,
1995 ; Xia et al., 1995 ; Villacres et al., 1998 ). However, the detection
of mRNA in the hippocampus for at least one  -stimulated adenylyl
cyclase, AC2 (Furuyama et al., 1993 ), suggests that there may be
additional mechanisms for generating the robust cAMP increases thought
to underlie synaptic plasticity. The goals of this research were to
determine whether AC4 is stimulated by  subunits in intact cells
and to determine the expression and localization of AC2 and AC4 in the hippocampus.
In this study, we demonstrated that AC4 is stimulated by
Gs-coupled receptors in intact HEK 293 cells. This is
consistent with previous in vitro data (Gao and Gilman,
1991 ) and recent work by Avidor-Reiss et al. (1997) using COS-7 cells
that demonstrated that AC4 is stimulated by recombinant or endogenous
Gs , respectively. Additionally, we found that
Gi-coupled receptor activation potentiates the response of
AC4 to Gs-coupled receptors in vivo.
Specifically, stimulation of AC4 by Gs-coupled receptors
was potentiated by activation of Gi-coupled somatostatin
receptors. Somatostatin potentiation of isoproterenol-stimulated AC4
was blocked by pertussis toxin. In addition, in transient transfection
experiments, coexpression of the C-terminal,  -binding region of
ARK1 (PH domain) or transducin (Gt) effectively blocked somatostatin potentiation
of 5-HT7A-stimulated AC4 activity. This indicates that AC4
responds to paired Gs and Gi inputs in
vivo with  potentiation. Similar findings have been observed
for AC2 in vivo (Federman et al., 1992 ; Lustig et al., 1993 ;
Koch et al., 1994 ). These results demonstrate that both AC2 and AC4 can
function as coincidence detectors of paired Gs and
Gi inputs. It has also been demonstrated that AC2 can
detect simultaneous activation of PKC and Gi (Tsu and Wong,
1996 ). It is possible that  potentiation of AC2 could also occur
via  activation of phospholipase C (Banno et al., 1998 ), which
then results in the activation of perhaps another PKC isoform. This would not be expected to occur with AC4 because AC4 has been
demonstrated to be insensitive to PKC (Jacobowitz et al., 1993 ).
Because coincidence detection of separate, temporally overlapping
signals is believed to be important for neuroplasticity (Bourne and
Nicoll, 1993 ), our results suggest a role for AC4 in addition to AC2 in
synaptic plasticity.
A second aspect of this study was directed at elucidating
immunohistochemically the localization of AC2 and AC4 in the mouse hippocampal formation. To this end, we demonstrated that both AC2 and
AC4 proteins are expressed in the hippocampus. The immunohistochemical labeling pattern for both AC2 and AC4 was for the most part
indistinguishable and colocalized with that for MAP2, a dendritic
and/or postsynaptic marker, in all regions of the hippocampal
formation. In the dentate gyrus, labeling was found in the proximal
dendrites and extended into the dendritic field in the molecular layer.
In CA3, AC2 and AC4 immunolabeling was concentrated in the CA3
pyramidal cell dendrites throughout the stratum lucidum. In the CA1
region, AC2 and AC4 labeling was concentrated along the apical
dendrites of the pyramidal cells and extended throughout the stratum
radiatum. This postsynaptic pattern is similar to that described by
Mons et al. (1995) using an antibody generated against a common domain in all adenylyl cyclase isoforms. At least at this level of resolution and compared with the labeling pattern for synaptophysin, AC2 and AC4
are not expressed presynaptically in the hippocampus. These results are
the first to demonstrate the localization of AC2 and AC4 proteins in
the hippocampus. Double labeling with markers for pre- and postsynaptic
sites (synaptophysin and MAP2, respectively) strongly indicate that
both AC2 and AC4 are localized postsynaptically along the dendrites in
all regions of the hippocampus.
Possible roles for  -stimulated adenylyl cyclases in synaptic
plasticity are as follows. AC2 may serve to integrate inputs from
multiple signaling pathways, because it can respond to either Gs or PKC and  from Gi with
potentiation in vivo (Federman et al., 1992 ; Lustig et al.,
1993 ; Tsu and Wong, 1996 ). Additionally, PKC may suppress the
responsiveness of AC2 to paired Gs and 
stimulation (Zimmermann and Taussig, 1996 ). These regulatory features
may allow for the generation of cAMP signals with the necessary spatial
and temporal characteristics to contribute to long-term changes in
synaptic strength (Backsai et al., 1993 ). Consistent with this notion,
mossy fiber-CA3 LTP has been reported to be dependent on activation of
Gi/Go-coupled opioid receptors (Williams
and Johnston, 1996 ) and pertussis toxin-sensitive G-proteins (Ito et
al., 1988 ). We have focused on  subunits released from Gi. However, it is possible that  subunits released
from Gq or other pertussis toxin-insensitive
G-proteins could facilitate potentiated adenylyl cyclase activity
in vivo, as has been postulated to occur in the frontal
cortex (Onali and Olianas, 1998 ).
A possible role for AC4 in synaptic plasticity in the hippocampus may
be to integrate Gs and Gi inputs, perhaps as a
complement to the signal generated by AC2. The presence of AC2 and AC4
in the hippocampus thus allows for flexibility in the generation of
robust cAMP increases necessary for synaptic plasticity. In addition to
relying on the Ca2+-stimulated adenylyl cyclases as
a means of eliciting cAMP-mediated long-term adaptive changes,
hippocampal neurons may have evolved with several distinct mechanisms
for expression of synaptic plasticity. It is possible that there exist
two (or more) parallel pathways involving cAMP that encode different
forms of synaptic plasticity. With respect to the AC4 immunolabeling
observed in the forebrain, it is intriguing that several of these areas
are sites in which synaptic plasticity has been demonstrated (e.g.,
neocortex and piriform cortex) (Hasselmo and Barkai, 1995 ; Cruikshank
and Weinberger, 1996 ).
In summary, these results demonstrate that AC4 can act as a coincidence
detector of paired Gs and Gi inputs. The
finding that both AC2 and AC4 proteins are expressed postsynaptically
in hippocampus suggests that these adenylyl cyclase isoforms may play a
role in certain forms of hippocampal synaptic plasticity.
 |
FOOTNOTES |
Received July 22, 1998; revised Sept. 28, 1998; accepted Oct. 15, 1998.
This work was supported by National Institutes of Health Grant 20498 to
D.R.S. We thank Drs. Karl Obrietan for providing thick tissue sections,
Jean-Christophe Deloulme for aid with Western blot analysis, and Ruth
Westenbroek for valuable discussions regarding the
immunohistochemistry. We thank Lisa Prichard, Scott Wong, Kien Trinh,
Jaime Athos, Bill Watt, and Drs. Guy Chan, Ulrika Lernmark, and Karl
Obrietan for critical reading of this manuscript. Confocal imaging and
analysis were performed at the William M. Keck Imaging Center
(University of Washington, Seattle, WA).
Correspondence should be addressed to Dr. Daniel R. Storm, Department
of Pharmacology, Box 357280, University of Washington, Seattle, WA
98195-7280.
Drs. Baker and Nielsen are coprimary authors.
 |
REFERENCES |
-
Andrade R
(1993)
Enhancement of beta-adrenergic responses by Gi-linked receptors in rat hippocampus.
Neuron
10:83-88[Web of Science][Medline].
-
Avidor-Reiss T,
Nevo I,
Saya D,
Bayewitch M,
Vogel Z
(1997)
Opiate-induced adenylyl cyclase superactivation is isozyme-specific.
J Biol Chem
272:5040-5047[Abstract/Free Full Text].
-
Backsai BJ,
Hochner B,
Mahaut-Smith M,
Adams SR,
Kaang B-K,
Kandel ER,
Tsien RY
(1993)
Spatially resolved dynamics of cAMP and protein kinase A subunits in Aplysia sensory neurons.
Science
260:222-226[Abstract/Free Full Text].
-
Bakalyar HA,
Reed RR
(1990)
Identification of a specialized adenylyl cyclase that may mediate odorant detection.
Science
250:1403-1406[Abstract/Free Full Text].
-
Banno Y,
Asano T,
Nozawa Y
(1998)
Stimulation by G protein betagamma subunits of phospholipase C beta isoforms in human platelets.
Thromb Haemost
79:1008-1013[Web of Science][Medline].
-
Bourne HR,
Nicoll R
(1993)
Molecular machines integrate coincident synaptic signals.
Cell [Suppl]
72:65-75.
-
Bradford MM
(1976)
A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding.
Anal Biochem
72:248-254[Web of Science][Medline].
-
Burns DL,
Hewlett EL,
Moss J,
Vaughan M
(1983)
Pertussis toxin inhibits enkephalin stimulation of GTPase in NG108-15 cells.
J Biol Chem
258:1435-1438[Abstract/Free Full Text].
-
Cali JF,
Zwaagstra JC,
Mons N,
Cooper DMF,
Krupinski J
(1994)
Type VIII adenylyl cyclase. A Ca2+/calmodulin-stimulated enzyme expressed in discrete regions of rat brain.
J Biol Chem
269:12190-12195[Abstract/Free Full Text].
-
Chen C,
Okayama H
(1987)
High-efficiency transformation of mammalian cells by plasmid DNA.
Mol Cell Biol
7:2745-2752[Abstract/Free Full Text].
-
Choi EJ,
Xia Z,
Villacres EC,
Storm DR
(1993)
The regulatory diversity of the mammalian adenylyl cyclases.
Curr Opin Cell Biol
5:269-273[Medline].
-
Cooper DMF,
Mons N,
Karpen JW
(1995)
Adenylyl cyclases and the interaction between calcium and cAMP signalling.
Nature
374:421-424[Medline].
-
Cruikshank SJ,
Weinberger NM
(1996)
Evidence for the Hebbian hypothesis in experience-dependent physiological plasticity of neocortex: a critical review.
Brain Res Rev
22:191-228[Medline].
-
Federman AD,
Conklin BR,
Schrader KA,
Reed RR,
Bourne HR
(1992)
Hormonal stimulation of adenylyl cyclase through Gi-protein beta gamma subunits.
Nature
356:159-161[Medline].
-
Feinstein PG,
Schrader A,
Bakalyar HA,
Tang WJ,
Krupinski J,
Gilman AG,
Reed RR
(1991)
Molecular cloning and characterization of a calcium calmodulin insensitive adenylyl cyclase (type II) from rat brain.
Proc Natl Acad Sci USA
88:10173-10177[Abstract/Free Full Text].
-
Franklin KJB,
Paxinos G
(1997)
In: The mouse brain. San Diego: Academic.
-
Frey U,
Huang YY,
Kandel ER
(1993)
Effects of cAMP simulate a late stage of LTP in hippocampal CA1 neurons.
Science
260:1661-1664[Abstract/Free Full Text].
-
Furuyama T,
Inagaki S,
Takagi H
(1993)
Distribution of type II adenylyl cyclase mRNA in the rat brain.
Mol Brain Res
19:165-170[Medline].
-
Gao B,
Gilman A
(1991)
Cloning and expression of a widely distributed (type IV) adenylyl cyclase.
Proc Natl Acad Sci USA
88:10178-10182[Abstract/Free Full Text].
-
Gereau RW,
Conn PJ
(1994)
A cyclic AMP-dependent form of associative synaptic plasticity induced by coactivation of
-adrenergic receptors and metabotropic glutamate receptors in rat hippocampus.
J Neurosci
14:3310-3318[Abstract]. -
Gierschik P
(1992)
ADP-ribosylation of signal-transducing guanine nucleotide-binding proteins by pertussis toxin.
Curr Top Microbiol Immunol
175:69-96[Web of Science][Medline].
-
Glatt CE,
Snyder SH
(1993)
Cloning and expression of an adenylyl cyclase localized to the corpus striatum.
Nature
361:536-538[Medline].
-
Goh JW,
Pennefather PS
(1989)
A pertussis toxin-sensitive G protein in hippocampal long-term potentiation.
Science
244:980-983[Abstract/Free Full Text].
-
Goh JW,
Pennefather PS
(1990)
Pertussis toxin prevents induction of hippocampal long-term potentiation in the stratum radiatum and stratum oriens inputs to CA1 neurons.
Brain Res
511:345-348[Web of Science][Medline].
-
Hasselmo ME,
Barkai E
(1995)
Cholinergic modulation of activity-dependent synaptic plasticity and associative memory function in a network biophysical simulation.
J Neurosci
15:6592-6604[Abstract/Free Full Text].
-
Hellevuo K,
Yoshimura M,
Kao M,
Hoffman PL,
Cooper DMF,
Tabakoff B
(1993)
A novel adenylyl cyclase sequence cloned from the human erythroleukemia cell line.
Biochem Biophys Res Commun
192:311-318[Web of Science][Medline].
-
Hellevuo K,
Yoshimura M,
Mons N,
Hoffman PL,
Cooper DMF,
Tabakoff B
(1995)
The characterization of a novel human adenylyl cyclase which is present in brain and other tissues.
J Biol Chem
270:11581-11589[Abstract/Free Full Text].
-
Hsia JA,
Moss J,
Hewlett EL,
Vaughan M
(1984)
ADP-ribosylation of adenylate cyclase by pertussis toxin: effects on inhibitory agonist binding.
J Biol Chem
259:1086-1090[Abstract/Free Full Text].
-
Huang YY,
Li XC,
Kandel ER
(1994)
cAMP contributes to mossy fiber LTP by initiating both a covalently mediated early phase and a macromolecular synthesis-dependent late phase.
Cell
79:69-79[Web of Science][Medline].
-
Huang YY,
Kandel ER,
Varshavsky L,
Brandon EP,
Qi M,
Idzerda RL,
McKnight GS,
Bourtchouladze R
(1995)
A genetic test of the effects of mutations in PKA on mossy fiber LTP and its relation to spatial and contextual learning.
Cell
83:1211-1222[Web of Science][Medline].
-
Impey S,
Wayman G,
Wu Z,
Storm DR
(1994)
The type I adenylyl cyclase functions as a coincidence detector for control of CRE-mediated transcription: synergistic regulation of transcription by Ca2+ and isoproterenol.
Mol Cell Biol
14:8272-8281[Abstract/Free Full Text].
-
Inglese J,
Luttrell LM,
Iniguez-Lluhi JA,
Touhara K,
Koch WJ,
Lefkowitz RJ
(1994)
Functionally active targeting domain of the beta-adrenergic receptor kinase: an inhibitor of G beta/gamma-mediated stimulation of type II adenylyl cyclase.
Proc Natl Acad Sci USA
91:3637-3641[Abstract/Free Full Text].
-
Ishikawa Y,
Katsushika S,
Chen L,
Halnon NJ,
Kawabe J,
Homcy CJ
(1992)
Isolation and characterization of a novel cardiac adenylyl cyclase cDNA.
J Biol Chem
267:13553-13557[Abstract/Free Full Text].
-
Ito I,
Okada D,
Sugiyama H
(1988)
Pertussis toxin suppresses long-term potentiation of hippocampal mossy fiber synapses.
Neurosci Lett
90:181-185[Web of Science][Medline].
-
Iyengar R
(1993)
Molecular and functional diversity of mammalian Gs stimulates adenylyl cyclases.
FASEB J
7:768-775[Abstract].
-
Jacobowitz O,
Chen J,
Premont RT,
Iyengar R
(1993)
Stimulation of specific types of Gs-stimulated adenylyl cyclases by phorbol ester treatment.
J Biol Chem
268:3829-3832[Abstract/Free Full Text].
-
Katada T,
Ui M
(1982)
ADP-ribosylation of the specific membrane protein of C6 cells by islet-activating protein associated with modification of adenylate cyclase activity.
J Biol Chem
257:7210-7216[Abstract/Free Full Text].
-
Katsushika S,
Chen L,
Kawabe J,
Nilakantan R,
Halnon NJ,
Homcy CJ,
Ishikawa Y
(1992)
Cloning and characterization of a sixth AC: types V and VI constitute a subgroup within the mammalian AC family.
Proc Natl Acad Sci USA
89:8774-8778[Abstract/Free Full Text].
-
Koch WJ,
Hawes BE,
Inglese J,
Luttrell LM,
Lefkowitz RJ
(1994)
Cellular expression of the carboxyl terminus of a G protein-coupled receptor kinase attenuates G beta/gamma-mediated signalling.
J Biol Chem
269:6193-6197[Abstract/Free Full Text].
-
Krupinski J,
Coussen F,
Bakalyar HA,
Tang WJ,
Feinstein PG,
Orth K,
Slaughter C,
Reed RR,
Gilman AG
(1989)
Adenylyl cyclase amino acid sequence: possible channel- or transporter-like structure.
Science
244:1558-1564[Abstract/Free Full Text].
-
Laemmli UK
(1970)
Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
Nature
227:680-685[Medline].
-
Lim C,
Blume HW,
Madsen JR,
Saper CB
(1997)
Connections of the hippocampal formation in humans: I. The mossy fiber pathway.
J Comp Neurol
385:325-351[Web of Science][Medline].
-
Lustig KD,
Conklin BR,
Herzmark P,
Taussig R,
Bourne HR
(1993)
Type II adenylyl cyclase integrates coincident signals from Gs, Gi, and Gq.
J Biol Chem
268:13900-13905[Abstract/Free Full Text].
-
Luttrell LM,
Hawes BE,
Touhara K,
van Biesen T,
Koch WJ,
Lefkowitz RJ
(1995)
Effect of cellular expression of pleckstrin homology domains on Gi-coupled receptor signalling.
J Biol Chem
270:12984-12989[Abstract/Free Full Text].
-
Mons N,
Harry A,
Dubourg P,
Premont RT,
Iyengar R,
Cooper DMF
(1995)
Immunohistochemical localization of adenylyl cyclase in rat brain indicates a highly selective concentration at synapses.
Proc Natl Acad Sci USA
92:8473-8477[Abstract/Free Full Text].
-
Neer EJ,
Lok JM,
Wolf LG
(1984)
Purification and properties of the inhibitory guanine nucleotide regulatory unit of brain adenylate cyclase.
J Biol Chem
259:14222-14229[Abstract/Free Full Text].
-
Nielsen MD,
Chan GC-K,
Poser SW,
Storm DR
(1996)
Differential regulation of type I and type VIII Ca2+-stimulated adenylyl cyclases by Gi-coupled receptors in vivo.
J Biol Chem
271:33308-33316[Abstract/Free Full Text].
-
Olianas MC,
Ingianni A,
Onali P
(1998)
Role of G protein
 subunits in muscarinic receptor-induced stimulation and inhibition of adenylyl cyclase activity in rat olfactory bulb.
J Neurochem
70:2620-2627[Web of Science][Medline]. -
Onali P,
Olianas MC
(1998)
Identification and characterization of muscarinic receptors potentiating the stimulation of adenylyl cyclase activity by corticotropin-releasing hormone in membranes of rat frontal cortex.
J Pharmacol Exp Ther
286:753-759[Abstract/Free Full Text].
-
Pian MS,
Dobbs LG
(1995)
Evidence for G beta/gamma-mediated cross-talk in primary cultures of lung alveolar cells.
J Biol Chem
270:7427-7430[Abstract/Free Full Text].
-
Premont RT,
Chen J,
Ma HW,
Ponnapalli M,
Iyengar R
(1992)
Two members of a widely expressed subfamily of hormone-stimulated adenylyl cyclases.
Proc Natl Acad Sci USA
89:9809-9813[Abstract/Free Full Text].
-
Premont RT,
Matsuoka I,
Mattei M-G,
Pouille Y,
Defer N,
Hanoune J
(1996)
Identification and characterization of a widely expressed form of adenylyl cyclase.
J Biol Chem
271:13900-13907[Abstract/Free Full Text].
-
Salomon Y,
Londos D,
Rodbell M
(1974)
A highly sensitive adenylate cyclase assay.
Anal Biochem
58:541-548[Web of Science][Medline].
-
Shen Y,
Monsma FJ,
Metcalf MA,
Jose PA,
Hamblin MW,
Sibley DR
(1993)
Molecular cloning and expression of a 5-hydroxytryptamine7 serotonin receptor subtype.
J Biol Chem
268:18200-18204[Abstract/Free Full Text].
-
Sunahara RK,
Dessauer CW,
Gilman AG
(1996)
Complexity and diversity of mammalian adenylyl cyclases.
Annu Rev Pharmacol Toxicol
36:461-480[Web of Science][Medline].
-
Tang WJ,
Gilman AG
(1991)
Type specific regulation of adenylyl cyclase by G protein beta/gamma subunits.
Science
254:1500-1503[Abstract/Free Full Text].
-
Taussig R,
Gilman AG
(1995)
Mammalian membrane-bound adenylyl cyclases.
J Biol Chem
270:1-4[Free Full Text].
-
Tsu RC,
Wong YH
(1996)
Gi-mediated stimulation of type II adenylyl cyclase is augmented by Gq-coupled receptor activation and phorbol ester treatment.
J Neurosci
16:1317-1323[Abstract/Free Full Text].
-
Villacres EC,
Wong ST,
Chavkin C,
Storm DR
(1998)
Type I adenylyl cyclase mutant mice have impaired mossy fiber long-term potentiation.
J Neurosci
18:3186-3194[Abstract/Free Full Text].
-
Wayman GA,
Impey S,
Wu Z,
Kindsvogel W,
Prichard L,
Storm DR
(1994)
Synergistic activation of the type I adenylyl cyclase by Ca2+ and Gs-coupled receptors in vivo.
J Biol Chem
269:25400-25405[Abstract/Free Full Text].
-
Wayman GA,
Hinds TR,
Storm DR
(1995)
Hormone stimulation of type III adenylyl cyclase causes Ca2+ oscillations in HEK-293 cells.
J Biol Chem
270:24108-24115[Abstract/Free Full Text].
-
Weisskopf MG,
Castillo PE,
Zalutsky RA,
Nicoll RA
(1994)
Mediation of hippocampal mossy fiber long-term potentiation by cyclic AMP.
Science
265:1878-1882[Abstract/Free Full Text].
-
West RE,
Moss J,
Vaughan M,
Liu T,
Liu T-Y
(1985)
Pertussis toxin-catalyzed ADP-ribosylation of transducin.
J Biol Chem
260:14428-14430[Abstract/Free Full Text].
-
Williams SH,
Johnston D
(1996)
Actions of endogenous opioids on NMDA receptor-independent long-term potentiation in area CA3 of the hippocampus.
J Neurosci
16:3652-3660[Abstract/Free Full Text].
-
Wong YH,
Federman A,
Pace AM,
Zachary I,
Evans T,
Pouyssegur J,
Bourne HR
(1991)
Mutant alpha subunits of Gi2 inhibit cyclic AMP accumulation.
Nature
351:63-65[Medline].
-
Wu ZL,
Thomas SA,
Villacres EC,
Xia Z,
Simmons ML,
Chavkin C,
Palmiter RD,
Storm DR
(1995)
Altered behavior and long-term potentiation in type I adenylyl cyclase mutant mice.
Proc Natl Acad Sci USA
92:220-224[Abstract/Free Full Text].
-
Xia ZG,
Refsdal CD,
Merchant KM,
Dorsa DM,
Storm DR
(1991)
Distribution of mRNA for the calmodulin-sensitive adenylate cyclase in rat brain: expression in areas associated with learning and memory.
Neuron
6:431-443[Web of Science][Medline].
-
Xia Z,
Choi EJ,
Blazynski C,
Storm DR
(1995)
Do the calmodulin stimulated adenylyl cyclases play a role in neuroplasticity?
Behav Brain Sci
18:429-440.
-
Yoshimura M,
Cooper DM
(1992)
Cloning and expression of a Ca2+ inhibitable adenylyl cyclase from NCB-20 cells.
Proc Natl Acad Sci USA
89:6716-6720[Abstract/Free Full Text].
-
Zimmermann G,
Taussig R
(1996)
Protein kinase C alters the responsiveness of adenylyl cyclases to G protein alpha and beta/gamma subunits.
J Biol Chem
271:27161-27166[Abstract/Free Full Text].
Copyright © 1999 Society for Neuroscience 0270-6474/99/191180-13$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
L. Yao, P. Fan, Z. Jiang, A. Gordon, D. Mochly-Rosen, and I. Diamond
Dopamine and Ethanol Cause Translocation of {epsilon}PKC Associated with {epsilon}RACK: Cross-Talk between cAMP-Dependent Protein Kinase A and Protein Kinase C Signaling Pathways
Mol. Pharmacol.,
April 1, 2008;
73(4):
1105 - 1112.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Yao, K. McFarland, P. Fan, Z. Jiang, Y. Inoue, and I. Diamond
Activator of G protein signaling 3 regulates opiate activation of protein kinase A signaling and relapse of heroin-seeking behavior
PNAS,
June 14, 2005;
102(24):
8746 - 8751.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Vanhoose and D. G. Winder
NMDA and {beta}1-Adrenergic Receptors Differentially Signal Phosphorylation of Glutamate Receptor Type 1 in Area CA1 of Hippocampus
J. Neurosci.,
July 2, 2003;
23(13):
5827 - 5834.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. W. Kinney, G. Starosta, A. Holmes, C. C. Wrenn, R. J. Yang, A. P. Harris, K. C. Long, and J. N. Crawley
Deficits in Trace Cued Fear Conditioning in Galanin-Treated Rats and Galanin-Overexpressing Transgenic Mice
Learn. Mem.,
July 1, 2002;
9(4):
178 - 190.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. R. Albert, N. Sajedi, S. Lemonde, and M. H. Ghahremani
Constitutive Gi2-dependent Activation of Adenylyl Cyclase Type II by the 5-HT1A Receptor. INHIBITION BY ANXIOLYTIC PARTIAL AGONISTS
J. Biol. Chem.,
December 10, 1999;
274(50):
35469 - 35474.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Omura, J. Nabekura, and N. Akaike
Intracellular Pathways of V1 and V2 Receptors Activated by Arginine Vasopressin in Rat Hippocampal Neurons
J. Biol. Chem.,
November 12, 1999;
274(46):
32762 - 32770.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. F. Liu, M. H. Ghahremani, M. M. Rasenick, K. H. Jakobs, and P. R. Albert
Stimulation of cAMP Synthesis by Gi-coupled Receptors upon Ablation of Distinct Galpha i Protein Expression. Gi SUBTYPE SPECIFICITY OF THE 5-HT1A RECEPTOR
J. Biol. Chem.,
June 4, 1999;
274(23):
16444 - 16450.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|